MCAM Expression Facilitates Melanoma–Endothelial Interactions and Promotes Metastatic Disease Progression
Experimental Dermatology · 2025-02 · 34 (2)
DOI: 10.1111/exd.70059 ↗At a glance
Journal article in Experimental Dermatology, published online on 2025-02-13. Written by Andreas Dominik Braun and 3 co-authors. Institution: Laboratory for Experimental Dermatology, Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany. Major MEDLINE topics: Melanoma, CD146 Antigen, Skin Neoplasms, Endothelial Cells. Cited 4 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Else Kröner Forschungskolleg Magdeburg, Deutsche Forschungsgemeinschaft.
Abstract (original language)
Invasive growth and metastatic dissemination represent the primary cause of death in cancer patients. In order to successfully detach from the primary tumour and establish metastases in distant tissues, cancer cells need to dynamically rewire their cell adhesion machinery. Here we revisit the potential association of MCAM, a member of the immunoglobulin superfamily that was initially identified as a melanoma antigen, with disease progression. Using immunohistochemical stainings and bioinformatic analyses of published datasets, we find abundant MCAM expression both in primary and metastatic human melanomas. In additional bioinformatic analyses, we show that MCAM is highly expressed in foetal melanocytes and subsequently downregulated during melanocyte maturation. Bioinformatic inference of cellular communication networks reveals that melanoma cells with high MCAM expression more actively engage in signalling crosstalk with endothelial cells. Experimental investigations demonstrate that disruption of MCAM in melanoma cells inhibits their migration on endothelial cell surfaces in vitro and decreases their ability to develop spontaneous lung metastases in vivo. Taken together, our results could not confirm the notion that MCAM expression represents a useful biomarker for disease progression but provide evidence that MCAM expression might represent part of a reactivated embryonal transcriptional program that facilitates melanoma–endothelial cell interactions during metastatic progression.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratory for Experimental Dermatology, Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany.
- Department of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, Germany.
ORCID profiles: Andreas Dominik Braun
Funding
- Else Kröner Forschungskolleg Magdeburg
- Deutsche Forschungsgemeinschaft
Cite
APA
Braun, A. D., Mengoni, M., Tüting, T., & Gaffal, E. (2025). MCAM Expression Facilitates Melanoma–Endothelial Interactions and Promotes Metastatic Disease Progression. Experimental Dermatology, 34(2). https://doi.org/10.1111/exd.70059
Vancouver
Braun AD, Mengoni M, Tüting T, Gaffal E. MCAM Expression Facilitates Melanoma–Endothelial Interactions and Promotes Metastatic Disease Progression. Experimental Dermatology. 2025;34(2). doi:10.1111/exd.70059
BibTeX
@article{Braun2025,
author = {Braun, Andreas Dominik and Mengoni, Miriam and Tüting, Thomas and Gaffal, Evelyn},
title = {MCAM Expression Facilitates Melanoma–Endothelial Interactions and Promotes Metastatic Disease Progression},
journal = {Experimental Dermatology},
year = {2025},
volume = {34},
number = {2},
doi = {10.1111/exd.70059}
}
EUVIMED